Welcome to the Department
of Pathology and Molecular Medicine
I am delighted to have recently assumed the role of Head in the Department of Pathology and Molecular Medicine (DPMM) at Queen’s. This is an exciting time of growth and innovation in our Department which is uniquely placed at the interfaces between basic biomedical sciences, clinical laboratory services and the emerging field of personalized molecular medicine.
DPMM is home to many vibrant research programs with focussed areas of excellence including cancer biology and molecular hemostasis. We host the Queen’s Laboratory for Molecular Pathology core research facility and also the Canadian Cancer Trials Group tumour bank. The well established DPMM Graduate program offers Master’s and PhD degrees and a recently added a combined BScH/MSc degree that allows students to transition 4th year undergraduate research projects into accelerated Master’s degrees.
Posted 2016 September 29
The Ontario Institute for Cancer Research (OICR) has announced $3.7 million in funding to form the Ontario Molecular Pathology Research Network (OMPRN), which will be based at Queen's University and led by Queen's researcher Dr. David LeBrun (Pathology and Molecular Medicine).
Dr. Christine Williams, Deputy Director and Vice-President of the OICR, announced the funding today in Kingston. The Network will bring together a number of institutions province-wide.
"We, as pathologists, are facing a whole new set of challenges," says Dr. LeBrun. "There are hundreds of potential new cancer drugs available for study so we need people doing research into the relevant diagnostics. We need to draw young pathologists into the research community, provide funding for this research and work to have more pathology content integrated into medical school curriculums."
Pathology is key to the early detection, diagnosis and treatment of cancer. An accurate diagnosis can provide better prognostic information and allow doctors to better target therapies. Pathology research can also lead to the development of new treatments that target specific cancer-driving mutations, genes and pathways, avoiding ineffective treatments with unwanted side effects. But as researchers' understanding of cancer, and its complexity, deepens, so too has the need for pathologists who can incorporate this new understanding into their daily routine, taking advantage of the latest technologies and knowledge to help patients.
"The Ontario Molecular Pathology Research Network's objectives in helping to improve the diagnosis of cancer will accelerate the pace of discovery while fostering collaboration amongst our young pathologists," says Reza Moridi, Minister of Research, Innovation and Science. "The Ontario government proudly supports this new initiative through the Ontario Institute for Cancer Research for it will help maintain the province's continued commitment to the cutting edge of research and development of better treatments for all patients."
Click here For the complete announcement
Posted 2016 September 12
I am pleased to announce that Dr. Harriet Feilotter has been named Chair of the CCO Molecular Oncology Testing Advisory Committee (MOTAC), formerly known as the Molecular Oncology Advisory Committee (MOAC).
Dr. Feilotter, a geneticist, is the Director of the Molecular Laboratory and Service Chief of Laboratory Genetics at Kingston General Hospital. In additional to her clinical role, Dr. Feilotter has a strong background in research, including translational research, with the focus of bringing new discovers through clinical trials to point-of-care patient applications.
Dr. Feilotter joined MOAC in 2014 and has been an active member of the committee since joining.
Please join me in congratulating Dr. Feilotter and welcoming her to the role of Chair, Molecular Oncology Testing Advisory Committee at CCO.
Jennifer Hart, MPA
Manager, Pathology and Laboratory Medicine Program
Clinical Programs and Quality Initiatives
CCO | Cancer Care Ontario
[see more News Archive]...
Monday October 3
8:30-9:30 Autopsy Conference - NOT SCHEDULED THIS WEEK
1:00-2:00 Hematopathology Review Richardson Lab Rm. 102
Tuesday October 4
9:00-10:00 Neuropathology Conference Autopsy Conference Rm
1:45-2:45 GI & Liver Conference Multihead Microscope Rm
Wednesday October 5
8:00-8:55 Resident Slide Review for the Royal College Exam Multihead Microscope Rm.
Dr. N. Parvinnejad
9:00-9:55 Micro Round Multihead Microscope Rm.
Dr. D. Berman
10:00-10:55 AP Seminar: Lung, Neo-plastic Richardson Lab Rm. 102
Dr. S. Boag
11:00-11:55 Journal Club: Pulmonary Richardson Lab Rm. 102
Drs. C. Atuegwu & S. Boag
Thursday October 6
12:30-1:30 Grand Rounds - Dr. Daniel Li Richardson Amphitheatre
The Hard (and Soft) Facts of IgG4-related disease
Friday October 7
9:00-9:30 Gross Rounds – Dr. I. Barsoum Gross Room
1:30-2:30 Hematopathology Morphology Round Autopsy Conference Room
Courses offered in 2016 September:
Courses offered in 2017 January:
ACADEMIC ANATOMICAL PATHOLOGISTS (2 positions)
Queen’s University, Kingston, Ontario, Canada
The Department of Pathology and Molecular Medicine in the Queen’s University Faculty of Health Sciences is recruiting
two (2) academic Anatomical Pathologists, one each with primary subspecialty training and diagnostic expertise in
dermatopathology and gastrointestinal pathology, respectively. (more)
Tier I Canada Research Chair in Bioinformatics
Faculty of Health Sciences and Department of Pathology and Molecular Medicine
Queen’s University, Kingston, Ontario, Canada.
Review of applications will commence on March 1,
2016 and will continue until the position is filled. (more)
Welcome to the Queen's Laboratory for Molecular Pathology
The QLMP is part of the Department of Pathology and Molecular Medicine at Queen's University, Kingston, Ontario. The QLMP provides rapid and economic advanced pathology services to researchers, students, clinicians, and private sector groups. The QLMP promotes productive interactions between scientists, clinicians, pathologists, and others by supporting research projects of common interest.
The QLMP offers a wide array of services including:
TMA design and construction
Whole slide scanning
Customized immunohistochemistry and immunofluoroscence
Image analysis tools
Secure web database access and storage
The Canadian National
Inherited Bleeding Disorder
Providing molecular diagnostic services to the Canadian inherited bleeding disorder community.